Allegion plc

(New York Stock Exchange)
Back to all articles
Slightly Bullish +25

Boston Trust Walden Corp Has $82.35 Million Position in Allegion PLC ...

AI-generated analysis

πŸ“ˆ Boston Trust Walden Corp lifted its position in Allegion by 8.1%, now owning 566,792 shares valued at $82.35 million.

πŸ“‰ Bank of America and Wells Fargo lowered price targets to $157 and $155 respectively with neutral or equal-weight ratings.

πŸš€ Evercore upgraded Allegion to a strong buy rating in a report dated April 13th.

πŸ’° The company reported Q1 revenue of $1.03 billion, matching consensus estimates despite missing EPS by $0.08.

πŸ”„ Allegion's Board approved a new $500 million share buyback program authorized on April 28th.

πŸ’΅ A quarterly dividend of $0.55 per share was paid to shareholders of record on June 15th.

πŸ“Š The stock trades at a P/E ratio of 19.22 with a market capitalization of $12.09 billion.

πŸ‘” SVP Robert C. Martens sold 3,993 shares in May for a total transaction value of approximately $547,640.

Bullish Signals
  • Boston Trust Walden Corp increased its stake by 8.1% to own $82.35 million worth of shares.
  • Pinnacle Bancorp Inc. significantly boosted its position by 255.6% in the fourth quarter.
  • Evercore upgraded the stock to a strong buy rating, contrasting with recent downgrades from other major banks.
  • Revenue grew 9.7% year-over-year to $1.03 billion, matching analyst expectations.
  • The company has approved a substantial $500 million share buyback program.
  • Allegion maintains a strong balance sheet with a current ratio of 1.91 and a debt-to-equity ratio of 0.97.
Risk Factors
  • Q1 earnings per share of $1.80 missed the consensus estimate of $1.88 by $0.08.
  • Major banks including Bank of America, Wells Fargo, and JPMorgan Chase have lowered their price targets to between $150 and $157.
  • The consensus analyst rating is currently a Hold with an average target price of $160.89.
  • SVP Robert C. Martens sold 3,993 shares in May, representing a 31.78% decrease in his personal ownership.
Full Analysis
Boston Trust Walden Corp increased its stake in Allegion PLC (NYSE: ALLE) by 8.1% in the first quarter, holding approximately 566,792 shares valued at $82.35 million. Several other institutional investors also adjusted their positions, with Pinnacle Bancorp Inc. boosting holdings by 255.6% and CYBER HORNET ETFs LLC acquiring a new stake. Hedge funds and institutional investors collectively own 92.21% of the company's outstanding stock. Analyst sentiment remains mixed following recent earnings results. Bank of America, Wells Fargo, and JPMorgan Chase lowered their price targets to between $150 and $157 with neutral or equal-weight ratings. Conversely, Evercore upgraded the stock to a strong buy. The consensus rating is currently a Hold with an average target price of $160.89. Allegion reported Q1 earnings of $1.80 per share, missing the consensus estimate of $1.88, though revenue matched expectations at $1.03 billion and grew 9.7% year-over-year. The company has set full-year 2026 guidance between $8.70 and $8.90 EPS. Additionally, the Board approved a new $500 million share buyback program authorized to repurchase up to 3.9% of outstanding shares. The stock recently paid a quarterly dividend of $0.55 per share, yielding 1.6%. Financial metrics show a market capitalization of $12.09 billion, a P/E ratio of 19.22, and a debt-to-equity ratio of 0.97. Insider trading activity includes SVP Robert C. Martens selling 3,993 shares in May, reducing his personal ownership by roughly 32%.